Enlivex Therapeutics (ENLV) Stock Chart & Stock Price History $1.09 +0.05 (+4.31%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$1.10 +0.00 (+0.46%) As of 06/20/2025 05:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Enlivex Therapeutics Stock Price Performance The Enlivex Therapeutics (ENLV) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 19.85%, with a year-to-date return of -6.84%. In the past month, the stock has increased 13.29%, reflecting recent market activity. As of the latest close, Enlivex Therapeutics traded at $1.09 with a market cap of $25.78 million and volume of 139,267 shares. Five years ago, the stock traded at $5.89, representing a 81.49% decrease over that period. At the time, it had a market cap of $79.09 million and a volume of 80,100 shares. Receive ENLV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Enlivex Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+5.83%1 Month Performance+13.29%3 Month Performance+4.31%Year-To-Date Performance-6.84%1 Year Performance-19.85%5 Year Performance-81.49% ENLV Stock Chart for Sunday, June, 22, 2025 ENLV Chart by TradingView Enlivex Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/20/2025$1.05$1.09+4.31%$1.17$1.03139,267 shs$25.78 million06/19/2025$1.05$1.05$1.08$1.0093,685 shs$24.71 million06/18/2025$1.03$1.05+1.46%$1.08$1.0093,685 shs$24.72 million06/17/2025$1.03$1.03$1.06$0.9938,620 shs$24.36 million06/16/2025$0.91$1.03+13.81%$1.07$0.93289,148 shs$24.36 million06/13/2025$0.94$0.91-3.72%$0.92$0.9021,988 shs$21.40 million06/12/2025$0.94$0.94-0.21%$0.98$0.9316,736 shs$22.23 million06/11/2025$0.96$0.94-1.88%$0.98$0.9329,165 shs$22.28 million06/10/2025$0.94$0.96+2.13%$0.99$0.9441,546 shs$22.71 million06/09/2025$0.97$0.94-2.83%$0.99$0.9334,716 shs$22.23 million Get the Latest News and Ratings for ENLV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enlivex Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/06/2025$0.92$0.97+5.15%$0.97$0.9257,603 shs$22.88 million06/05/2025$0.93$0.92-1.08%$0.96$0.9223,504 shs$21.76 million06/04/2025$0.94$0.93-1.10%$0.96$0.9230,807 shs$22.00 million06/03/2025$0.94$0.94+0.03%$0.98$0.9346,193 shs$22.24 million06/02/2025$0.96$0.94-2.43%$0.97$0.9339,850 shs$22.23 million05/30/2025$0.95$0.96+1.84%$0.97$0.936,770 shs$22.79 million05/29/2025$0.96$0.95-0.94%$0.98$0.9248,328 shs$22.37 million05/28/2025$0.95$0.96+0.63%$1.02$0.9497,239 shs$22.59 million05/27/2025$0.98$0.95-2.67%$1.03$0.9268,361 shs$22.45 million05/26/2025$0.98$0.98$0.98$0.9616,709 shs$23.06 million05/23/2025$0.96$0.98+1.34%$0.98$0.9616,709 shs$23.06 million05/22/2025$0.98$0.96-1.78%$1.00$0.9619,052 shs$22.76 million05/21/2025$0.99$0.98-1.06%$0.99$0.9650,686 shs$23.17 million Related Companies OPTN Stock Chart MGNX Stock Chart IVVD Stock Chart GALT Stock Chart HLVX Stock Chart MIST Stock Chart ADAG Stock Chart COYA Stock Chart CHRS Stock Chart UNCY Stock Chart Receive ENLV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Enlivex Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ENLV) was last updated on 6/22/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe Biggest Story of My Decade-Long Career in Silicon ValleySteve Jobs' Lost 'Product' Could Save Tesla On July 21st, a revolutionary announcement could transform Tesl...InvestorPlace | SponsoredA grave, grave error.It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been cri...Porter & Company | SponsoredMost Bitcoin holders have no idea this existsHere’s what 99% of Bitcoin holders don’t know: There’s a way to amplify your Bitcoin gains without buying m...Brownstone Research | SponsoredSocial Security Boss drops huge Elon announcement…Elon's Successor? Elon Musk and President Trump's new feud is all over the news... but before he left Washi...Altimetry | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredYour Guide to Outperforming the Market - Guaranteed.Join the Dream Team and see how we can guarantee stock market wins Credentials are a good thing, especiall...Zacks | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enlivex Therapeutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enlivex Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.